Virumist® inhaler

The Virumist® inhaler is an exciting product currently under development with a team from Cardiff University and University College Dublin, funded through the Celtic Advanced Life Sciences Innovation Network (CALIN). Using the power of natural proteins, it will act as prophylaxis or treatment for viral conditions affecting the upper respiratory tract. This offers a promising avenue for people globally experiencing symptoms, from the common cold to more serious infections such as influenza and, of course, COVID-19.